Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Pancreatic Neoplasms × Insulin × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Oligomenorrhea 1 Insulin Resistance 1 Hyperandrogenism 1 Hirsutism 1 Diabetes Mellitus, Type 1 1

Interventions

Blood Specimen Collection 16 Pancreaticoduodenectomy 12 Surveys and Questionnaires 10 Endoscopic Ultrasound-Guided Fine Needle Aspiration 8 Observation 7 Pancreatectomy 6 Biopsy 6 Specimen Handling 5 Gemcitabine 5 Endosonography 5 Electroporation 5 Data Collection 5 Biopsy, Fine-Needle 5 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Liquid Biopsy 4 Immunohistochemistry 4 Immunologic Techniques 3 Drug Therapy 3 Cholangiopancreatography, Endoscopic Retrograde 3 Albumin-Bound Paclitaxel 3 irinotecan sucrosofate 2 folfirinox 2 Taxes 2 Surgical Procedures, Operative 2 Sulfonylurea Compounds 2 Secretin 2 Radiosurgery 2 Positron Emission Tomography Computed Tomography 2 Palliative Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05663515 2026-03-19

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡